Heat’s Hidden Toll: Aging Acceleration Revealed
A recent study reported significant associations between increased heat days and accelerated epigenetic aging [1]. Heat alters DNA While warm summer days on […]
A recent study reported significant associations between increased heat days and accelerated epigenetic aging [1]. Heat alters DNA While warm summer days on […]
According to an open-label study from Washington University in St. Louis, the anti-amyloid drug gantenerumab reduced the risk of developing familial Alzheimerâs disease in a subgroup of participants [1]. Is...
According to an open-label study from Washington University in St. Louis, the anti-amyloid drug gantenerumab reduced the risk of developing familial Alzheimerâs […]
Startup boasts pipeline of candidates targeting neuromuscular, neurodegenerative and cardio-metabolic diseases. Belgian biotech Augustine Therapeutics has raised $84.8 million in … Continue reading "Augustine Therapeutics lands $85m to advance HDAC6...
TruDiagnostic Founder Ryan Smith on personalized testing, disease risk prediction and how lifestyle choices can rewrite your health future. Longevity … Continue reading "‘Epigenetic testing puts control back into our...
Higher and more intense levels of physical activity may not benefit life span as much as previously thought, a new study in twins finds, highlighting multiple factors that play a...
Sens.ai Founder Paola Telfer on staving off cognitive decline and extending peak performance with transformative neurotechnology. âIn an era where … Continue reading "‘Very early detection of cognitive decline is...
Immorta Bio is developing autologous stem cell and immunotherapy solutions to combat aging and enhance cellular regeneration. Aging is the … Continue reading "Harnessing the power of personalized cell therapy"...
Research also identifies key methylation sites, along with processes and transcription factor targets linking epigenetics to health and aging. A … Continue reading "New study shows CheekAge clock is âsignificantly...
Biotech gains DSMB approval to escalate dosing as it advances novel organ regeneration therapy for end-stage liver disease. LyGenesis, a … Continue reading "LyGenesis progresses Phase 2a clinical trial in...